Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CASI Pharmaceuticals (CASI) Minority Interest (2021 - 2022)

Historic Minority Interest for Pharmaceuticals (CASI) over the last 2 years, with Q4 2022 value amounting to $22.4 million.

  • Pharmaceuticals' Minority Interest fell 468.52% to $22.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $22.4 million, marking a year-over-year decrease of 468.52%. This contributed to the annual value of $22.4 million for FY2022, which is 468.52% down from last year.
  • As of Q4 2022, Pharmaceuticals' Minority Interest stood at $22.4 million, which was down 468.52% from $23.5 million recorded in Q4 2021.
  • Pharmaceuticals' 5-year Minority Interest high stood at $23.5 million for Q4 2021, and its period low was $22.4 million during Q4 2022.